Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Bigley

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|January 5, 2000
Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liverJ V Rogers, B E Hull, P S Fink, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1984
Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss miceC L Gould, M L Trombley, N J Bigley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 3, 1998
Cytokines produced early in picornavirus infection reflect resistance or susceptibility to diseaseR E Curiel, K M Mason, T D Dryden, et al.
Vaccine|April 9, 1999
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein DP E Cruz, P L Khalil, T D Dryden, et al.
Journal of Leukocyte Biology|May 19, 2001
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|January 5, 2000
Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liverJ V Rogers, B E Hull, P S Fink, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1984
Replication of diabetogenic and nondiabetogenic variants of encephalomyocarditis (EMC) virus in ICR Swiss miceC L Gould, M L Trombley, N J Bigley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 3, 1998
Cytokines produced early in picornavirus infection reflect resistance or susceptibility to diseaseR E Curiel, K M Mason, T D Dryden, et al.
Vaccine|April 9, 1999
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein DP E Cruz, P L Khalil, T D Dryden, et al.
Journal of Leukocyte Biology|May 19, 2001
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.
Pageof 3